Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Interim Results

27 Sep 2005 12:09

Azure Holdings Plc (" Company") Interim results for the six months ended 30 June 2005 Chairman's statementIn the six months ended 30 June 2005 the Company incurred a loss before andafter taxation of ‚£74,000 (2004: ‚£229,000).Because of the lack of cash in the Company, creditors have increased butcontinue to be supportive.The directors are continuing to keep overheads to a minimum, the expenses beingthose necessary to maintain the Company's listing on AIM.The board continues to seek an acquisition for the Company.Owing to a technicality, the Company no longer has any authority to issue anyof its share capital and will therefore be convening an extraordinary generalmeeting for this purpose.Nicolas GreenstoneChairman27 September 2005Azure Holdings plcProfit and Loss Accountfor the six months ended 30 June 2005 6 months 6 months Year ended ended 30 ended 30 31 December June 2004 2004 June 2005 (unaudited) (audited) (unaudited) ‚£'000 ‚£'000 ‚£'000 Turnover - - - Administrative expenses (74) (229) (345) Operating loss (74) (229) (345) Loss on ordinary activities before (74) (229) (345)taxation Tax on loss on ordinary activities - - - Loss on ordinary activities after (74) (229) (345)taxation Retained loss for the period (74) (229) (345) Loss per ordinary share (0.15p) (0.65p) (0.86p) The profit and loss account has been prepared on the basis that all operationsare continuing operations. All recognised gains or losses are dealt withthrough the profit and loss account or statement of recognised gains andlosses.Azure Holdings plcBalance Sheetas at 30 June 2005 30 June 2005 30 June 31 December 2004 2004 (unaudited) (unaudited) (audited) ‚£'000 ‚£'000 ‚£'000 Current assets Debtors 3 14 7 Cash at bank and in hand 1 10 14 4 24 21 Creditors: amounts falling due within one (147) (81) (90)year Net current liabilities (143) (57) (69) Total assets less current liabilities (143) (57) (69) Net liabilities (143) (57) (69) Capital and reserves Called up Share Capital 5,475 5,371 5,475 Share Premium 10,279 10,279 10,279 Profit and loss account (15,897) (15,707) (15,823) Equity shareholders deficit (143) (57) (69) Azure Holdings plcCash Flow Statementfor the six months ended 30 June 2005 6 months ended 6 months ended 30 June 2005 30 June 2004 (unaudited) (unaudited) ‚£'000 ‚£'000 Net cash outflow from operating (13) (214)activities Financing Issue of ordinary shares - 105 Decrease in cash (13) (109)Azure Holdings plcNotes to the Interim Results 1. The interim results are unaudited and do not constitute statutory accounts within the meaning of section 240 of the Companies Act 1985. The figures for the year ended 31 December 2004 have been extracted from the statutory accounts filed with the registrar of companies on which the auditors gave an unqualified report. 2. The interim results have been prepared using the accounting policies set out in the statutory accounts for the year ended 31 December 2004. 3. The comparative figures for the unaudited interim results for the period ended 30 June 2004 are stated as announced on 29 September 2004. 4. Loss per share The earnings per share for the six months ended 30 June 2005 has beencalculated on the basis of the loss after taxation for the period of ‚£74,000(2004: ‚£229,000 ) and the weighted average number of shares in issue during theperiod of 48,317,569 (2004: 35,417,565). 5. The directors do not propose to pay a dividend for the period. 6. Copies of the interim results are available from the Company's registered office, One Great Cumberland Place, London, W1H 7AL. ENDAZURE HOLDINGS PLC
Date   Source Headline
5th May 20091:00 pmRNSIssue of Equity
30th Apr 20097:00 amRNSTotal Voting Rights
27th Apr 20097:00 amRNSIssue of Equity
16th Apr 20093:05 pmRNSHolding(s) in Company
16th Apr 20097:00 amRNSIssue of Equity
9th Apr 20097:00 amRNSIssue of Equity
6th Apr 20099:59 amRNSHolding(s) in Company
31st Mar 20097:00 amRNSIssue of Equity and Directors' Shareholdings
31st Mar 20097:00 amRNSUpdate to the Sale of Shares Agreement
12th Mar 20097:00 amRNSValiRx Announces Promising In Vivo Data
27th Feb 20097:00 amRNSTotal Voting Rights
13th Feb 200910:52 amRNSResult of EGM
30th Jan 20097:00 amRNSTotal Voting Rights
29th Jan 200912:07 pmRNSAvailability of circular
28th Jan 200911:55 amRNSProposed Reorganisation and General Meeting
5th Jan 20092:50 pmRNSIssue of Equity
31st Dec 20089:00 amRNSTotal Voting Rights
15th Dec 20087:00 amRNSGlobal Distribution Agreement
5th Dec 20082:00 pmRNSChange of Adviser
27th Nov 20084:19 pmRNSIssue of Equity
16th Sep 20087:00 amRNSUpdate on cancer detection test
11th Sep 20087:00 amRNSInterim Results
10th Sep 200810:33 amRNSNotice of Results
18th Aug 20084:02 pmRNSAppointment of director
31st Jul 20087:00 amRNSTotal Voting Rights
28th Jul 20082:48 pmRNSAGM Statement
23rd Jul 20084:02 pmRNSDirector's Dealing
14th Jul 20082:23 pmRNSDirector/PDMR Shareholding
14th Jul 20087:00 amRNSValiRx acquires Cronos Therap
9th Jul 20087:00 amRNSValiRx Acquires Global Rights
30th Jun 20084:38 pmRNSJoint Broker Appointment
30th Jun 20087:00 amRNSFinal Results
26th Jun 20087:00 amRNSTherapeutic Pipeline - in viv
23rd Jun 20088:00 amRNSNotice of Results
5th Jun 20089:13 amRNSHolding(s) in Company
30th May 20087:00 amRNSTotal Voting Rights
15th May 200812:37 pmRNSHolding(s) in Company
12th May 20084:42 pmPRNStatement re Placing of Shares
8th May 20088:05 amRNSIssue of Equity
7th May 20082:20 pmRNSHolding(s) in Company
2nd May 200811:35 amRNSResult of EGM
30th Apr 20087:00 amRNSTotal Voting Rights
7th Apr 20085:13 pmRNSNotice of EGM and Placing
18th Mar 20087:50 amPRNValibio Research Update
13th Feb 20087:55 amPRNLetter of Intent
29th Jan 20087:00 amPRNAustralian GeneICE Patent Granted
23rd Jan 20087:00 amPRNMorphogenesis Update
17th Jan 20087:00 amPRNGeneICE – CRT Research Update
31st Dec 20077:00 amRNSTotal Voting Rights
12th Dec 200711:08 amRNSCollaboration Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.